Detalhe da pesquisa
1.
Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial.
Gastroenterology
; 141(3): 900-908.e1-2, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21699796
2.
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.
Gastroenterology
; 140(3): 840-9; quiz e12, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21129375
3.
Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C.
Am J Gastroenterol
; 107(9): 1388-98, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22688849
4.
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
Hepatology
; 53(4): 1100-8, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21480316
5.
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
Hepatology
; 54(2): 396-405, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21520194
6.
YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C.
Liver Int
; 32(4): 665-74, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22103814
7.
Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
Hepatology
; 52(3): 833-44, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20564351
8.
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.
Gut
; 59(10): 1401-9, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20675691
9.
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
Gastroenterology
; 136(1): 138-48, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18848939
10.
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
Gastroenterology
; 137(6): 1986-94, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19747918
11.
Peginterferon therapy for HBeAg-negative chronic hepatitis B: less than meets the eye.
Am J Gastroenterol
; 105(8): 1770-2, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20686463
12.
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
Hepatology
; 50(5): 1360-9, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19676128
13.
Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis.
Clin Gastroenterol Hepatol
; 7(2): 219-26, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19068241
14.
Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C.
Hepatology
; 48(5): 1412-9, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18816437
15.
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.
Hepatology
; 47(2): 605-12, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18157835
16.
Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.
Clin Gastroenterol Hepatol
; 6(2): 234-41, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18237873
17.
Processes to manage analyses and publications in a phase III multicenter randomized clinical trial.
Trials
; 15: 159, 2014 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24886378
18.
Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers.
Infect Control Hosp Epidemiol
; 30(10): 1000-5, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19743901
19.
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
Gastroenterology
; 132(1): 103-12, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17241864
20.
Looking to the future: new agents for chronic hepatitis B.
Am J Gastroenterol
; 101 Suppl 1: S19-25, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16448448